Argitalpenak (128) VIRGINIA MERINO SANJUAN argitalpenak

2024

  1. Impact of Time on Parameters for Assessing the Microstructure Equivalence of Topical Products: Diclofenac 1% Emulsion as a Case Study

    Pharmaceutics, Vol. 16, Núm. 6

  2. In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug

    Pharmaceutics, Vol. 16, Núm. 3

  3. Las pruebas ECOE en el Grado de Farmacia dela Universitat de València, una evaluación global de conocimientos, competencias y habilidades

    Pharmaceutical care España, Vol. 26, Núm. 2, pp. 307-307

  4. Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole

    Pharmaceutics, Vol. 16, Núm. 5

2023

  1. Evolución de parámetros representativos de la estructura interna de diclofenaco emulgel 1% durante el periodo de conservación

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  2. Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union

    Pharmaceutics, Vol. 15, Núm. 2

2022

  1. Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen

    International Journal of Pharmaceutics, Vol. 614

  2. Transdermal formulations and strategies for the treatment of osteoporosis

    Journal of Drug Delivery Science and Technology, Vol. 69

2021

  1. 3d printing of temporary prostheses for controlled-release of drugs: Design, physical characterization and preliminary studies

    Pharmaceuticals, Vol. 14, Núm. 12

  2. Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 166, pp. 175-181

  3. Development, characterization, and ex vivo evaluation of an insert for the ocular administration of progesterone

    International Journal of Pharmaceutics, Vol. 606

  4. In vitro skin penetration of bronidox, bronopol and formaldehyde from cosmetics

    Regulatory Toxicology and Pharmacology, Vol. 122

  5. Nuevos hidrogeles para favorecer la cicatrización

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 175-176

  6. Variabilidad en el perfil de liberación de diclofenaco, formulado como emulgel 1 %, durante su periodo de validez

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 195-197

2020

  1. Candesartan cilexetil in vitro–in vivo correlation: Predictive dissolution as a development tool

    Pharmaceutics, Vol. 12, Núm. 7, pp. 1-21

  2. Development of an open source platforms for improving the learning process in pharmacy

    EDULEARN20 Proceedings: 12th International Conference on Education and New Learning Technologies (July 6th-7th, 2020, Online)

  3. Erratum: Assessment of the inter-batch variability of microstructure parameters in topical semisolids and impact on the demonstration of equivalence (Pharmaceutics, (2019) 11, 10.3390/pharmaceutics11100503)

    Pharmaceutics

  4. New insights of oral colonic drug delivery systems for inflammatory bowel disease therapy

    International Journal of Molecular Sciences, Vol. 21, Núm. 18, pp. 1-30

  5. Proyecto ApS multidisciplinar de la Facultat de Farmàcia de la Universitat de València

    El papel del Aprendizaje-Servicio en la construcción de una ciudadanía global (UNED - Universidad Nacional de Educación a Distancia), pp. 563-566

  6. Statistical methods for quality equivalence of topical products. 0.5 mg/g betamethasone ointment as a case-study

    Pharmaceutics, Vol. 12, Núm. 4